Chronic Therapy With Elamipretide (MTP-131), a Novel Mitochondria-Targeting Peptide, Improves Left Ventricular and Mitochondrial Function in Dogs With Advanced Heart Failure.
about
Oxidative stress during acetaminophen hepatotoxicity: Sources, pathophysiological role and therapeutic potentialDistinct membrane properties are differentially influenced by cardiolipin content and acyl chain composition in biomimetic membranesSilent disease progression in clinically stable heart failure.Expert consensus document: Mitochondrial function as a therapeutic target in heart failureHeart Failure with Preserved Ejection Fraction and Future Pharmacological Strategies: a Glance in the Crystal Ball.Molecular Mechanisms Underlying Cardiac Adaptation to Exercise.Mitochondrial therapy improves limb perfusion and myopathy following hindlimb ischemia.Targeting Metabolic Modulation and Mitochondrial Dysfunction in the Treatment of Heart Failure.Energetic mitochondrial failing in vitiligo and possible rescue by cardiolipin.Mitochondrial energetics and calcium coupling in the heart.Mitochondria Protection after Acute Ischemia Prevents Prolonged Upregulation of IL-1β and IL-18 and Arrests CKD.Mitoprotection attenuates myocardial vascular impairment in porcine metabolic syndrome.The mitochondrial-targeted peptide, SS-31, improves glomerular architecture in mice of advanced age.Loss of Metabolic Flexibility in the Failing Heart.Mitochondrial ROS Drive Sudden Cardiac Death and Chronic Proteome Remodeling in Heart Failure
P2860
Q28077959-FD24DFFF-71EF-4968-8DE2-5EB703666438Q28397811-2EBAEC8A-EEBF-494F-A1AC-82F9BD8B6448Q33578212-5B24A30B-214A-4826-B2E1-B9D96E313715Q37699474-F4F2ACB6-34EC-483B-98BE-D7A065BE4DAFQ38665806-D038F1DE-3F12-47E7-8412-1A809A7F9D3DQ39280811-15338C99-7668-4B32-B8A7-F4B30B362E52Q40961867-A0CAE80D-FAD1-47DC-85E6-D57735830131Q41297700-E0464BC6-17CC-4059-93E8-AA5F560B11F9Q45070729-EFB63730-F671-424C-A065-AEEE926E7CD3Q46430314-6FEA2260-77C3-4C11-8795-BC6272182172Q46455327-E1454090-36B7-46E1-A4A9-27698EAA6CACQ49356498-088CF0BC-DF3D-4B6E-8B5D-55D29A251894Q51210259-B871DC1F-EBEB-4CB4-90BE-F6DE6DD10C01Q55341036-583F3D79-3324-4779-9711-7450E88CE855Q57095732-F1A5C713-4546-4AAA-BEF5-B563C9A1ED3B
P2860
Chronic Therapy With Elamipretide (MTP-131), a Novel Mitochondria-Targeting Peptide, Improves Left Ventricular and Mitochondrial Function in Dogs With Advanced Heart Failure.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Chronic Therapy With Elamipret ...... s With Advanced Heart Failure.
@ast
Chronic Therapy With Elamipret ...... s With Advanced Heart Failure.
@en
type
label
Chronic Therapy With Elamipret ...... s With Advanced Heart Failure.
@ast
Chronic Therapy With Elamipret ...... s With Advanced Heart Failure.
@en
prefLabel
Chronic Therapy With Elamipret ...... s With Advanced Heart Failure.
@ast
Chronic Therapy With Elamipret ...... s With Advanced Heart Failure.
@en
P2093
P2860
P1476
Chronic Therapy With Elamipret ...... s With Advanced Heart Failure.
@en
P2093
Hani N Sabbah
Kefei Zhang
Mengjun Wang
Ramesh C Gupta
Smita Kohli
Souheila Hachem
P2860
P304
P356
10.1161/CIRCHEARTFAILURE.115.002206
P577
2016-02-01T00:00:00Z